We are live on
!
Find out more
DB
Dmitry Balyasny Balyasny Asset Management
AUM
$80.2B
1-Year Est. Return
51.53%
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
This Fund
S&P 500
This Quarter
Est. Return
+12.46%
1 Year Est. Return
+51.53%
3 Year Est. Return
+149.76%
5 Year Est. Return
+199.37%
10 Year Est. Return
+1,172.21%
AUM
$36.5B
AUM Growth
+$3.93B
(+12%)
Cap. Flow
+$651M
Cap. Flow
% of AUM
1.78%
Top 10 Holdings %
Top 10 Hldgs %
7.68%
Holding
3,587
New
780
Increased
747
Reduced
671
Closed
866
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$223M |
| 2 |
TJX Companies
TJX
|
+$191M |
| 3 |
TransDigm Group
TDG
|
+$157M |
| 4 |
Ingersoll Rand
IR
|
+$155M |
| 5 |
BP
BP
|
+$152M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$300M |
| 2 |
Eaton
ETN
|
+$261M |
| 3 |
Union Pacific
UNP
|
+$252M |
| 4 |
Analog Devices
ADI
|
+$240M |
| 5 |
SWCH
Switch, Inc. Class A Common Stock
SWCH
|
+$226M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 11.39% |
| 2 | Financials | 11.28% |
| 3 | Technology | 9.98% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Healthcare | 8.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Citigroup
C
$221B
| $18.3M | 0.05% |
405,058
+185,494
| +84% | +$8.43M |
|
|
RADI
502
DELISTED
Radius Global Infrastructure, Inc. Class A Common Stock
RADI
| $18.3M | 0.05% |
1,546,590
+336,080
| +28% | +$3.48M |
|
503
SL Green Realty
SLG
$4.07B
| $18.2M | 0.05% |
539,573
+516,855
| +2,275% | +$19.7M |
|
504
Toast
TOST
$21.2B
| $18.2M | 0.05% |
1,008,928
-423,356
| -30% | -$7.96M |
|
505
monday.com
MNDY
$3.84B
| $18.1M | 0.05% |
148,051
+105,378
| +247% | +$11M |
|
|
ISEE
506
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $18.1M | 0.05% |
843,311
-839,924
| -50% | -$17.9M |
|
507
National Health Investors
NHI
$3.6B
| $18M | 0.05% |
+343,802
| New | +$18.8M |
|
508
Kimco Realty
KIM
$16.1B
| $17.9M | 0.05% |
846,646
+439,973
| +108% | +$9.25M |
|
509
CALL
Bristol-Myers Squibb
BMY
$137B
| $17.9M | 0.05% |
248,400
| – | – |
|
510
Universal Health Services
UHS
$10.4B
| $17.8M | 0.05% |
126,637
+117,956
| +1,359% | +$13.9M |
|
|
SGEN
511
DELISTED
Seagen Inc. Common Stock
SGEN
| $17.8M | 0.05% |
138,499
+119,437
| +627% | +$15.4M |
|
512
PUT
Mastercard
MA
$509B
| $17.7M | 0.05% |
51,000
| – | – |
|
513
PUT
AbbVie
ABBV
$468B
| $17.7M | 0.05% |
109,500
| – | – |
|
514
MasterBrand
MBC
$1.85B
| $17.6M | 0.05% |
+2,333,346
| New | +$19.1M |
|
515
Health Catalyst
HCAT
$115M
| $17.6M | 0.05% |
1,655,946
+516,367
| +45% | +$4.99M |
|
|
SWN
516
DELISTED
Southwestern Energy Company
SWN
| $17.6M | 0.05% |
3,005,695
+1,180,984
| +65% | +$7.76M |
|
517
PUT
Advanced Micro Devices
AMD
$773B
| $17.5M | 0.05% |
270,900
+227,500
| +524% | +$15M |
|
518
CALL
Intuitive Surgical
ISRG
$134B
| $17.5M | 0.05% |
66,100
-391,400
| -86% | -$95.4M |
|
|
HTO
519
H2O America
HTO
$2.66B
| $17.4M | 0.05% |
+214,912
| New | +$15.4M |
|
520
LivaNova
LIVN
$4.34B
| $17.4M | 0.05% |
313,007
+206,774
| +195% | +$10.6M |
|
521
Cintas
CTAS
$81.6B
| $17.2M | 0.05% |
152,328
+17,320
| +13% | +$1.87M |
|
522
Hancock Whitney
HWC
$6.05B
| $17.2M | 0.05% |
354,696
+139,899
| +65% | +$7.23M |
|
523
XPeng
XPEV
$11.7B
| $17.2M | 0.05% |
1,725,573
+1,544,744
| +854% | +$13.9M |
|
524
Group 1 Automotive
GPI
$3.12B
| $17.1M | 0.05% |
+95,018
| New | +$16.7M |
|
525
BioNTech
BNTX
$29.3B
| $17.1M | 0.05% |
113,528
+105,691
| +1,349% | +$16.3M |
|
Similar funds
CBU
Dmitry Balyasny's Q4 2022 Portfolio in Review
As of Q4 2022, Dmitry Balyasny held 3,587 positions worth $36.5B, up 12% from $32.6B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Dmitry Balyasny's Q4 2022 filing shows 780 new, 747 increased, 671 reduced and 866 closed positions. Its largest new stake was TJX Companies: 2,589,145 shares worth $206M. The largest sale was ZENDESK INC, an estimated $300M.
By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 12% a quarter earlier, followed by Financials and Technology.
- Dmitry Balyasny's largest Q4 2022 buy was TJX Companies: 2,589,145 shares worth $206M.
- Dmitry Balyasny added most to Visa in Q4 2022, an estimated $223M increase.
- Dmitry Balyasny's biggest Q4 2022 reduction was Union Pacific, cutting an estimated $252M.
- Dmitry Balyasny fully exited ZENDESK INC in Q4 2022, selling an estimated $300M.
- Dmitry Balyasny's ten largest holdings make up 7.7% of its $36.5B portfolio in Q4 2022.
- Dmitry Balyasny opened 780 new positions and closed 866 in Q4 2022.
- Dmitry Balyasny's portfolio value rose 12% quarter-over-quarter to $36.5B.
Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.